You haven't searched anything yet.
Company Overview:
Myeloid Therapeutics is a clinical stage immunology company, engineering cutting-edge RNA technology to program immune cells to combat cancer and other deadly diseases. Myeloid is headquartered in Cambridge, MA. For additional information, please visithttps://www.myeloidtx.com/and follow us onLinkedIn and X/Twitter.
Position Summary:
Myeloid Therapeutics is seeking an innovation-driven Associate Director to join our RetroT Gene Editing team and contribute to the engineering and development of novel gene editing systems.
MyeloidTx has developed CRISPR-Enabled Autonomous Transposable Element (CREATE), a genome editing system that combines the programmability and precision of CRISPR/Cas9 with the RNA-mediated gene insertion capabilities of the human LINE1 (L1) element. CREATE represents a significant advancement in gene editing technology, establishing a new paradigm of RNA-based
We are seeking an Associate Director to enhance the CREATE technology, focusing on elevating editing efficiencies and broadening its application to disease-relevant primary cell types. This role offers the opportunity to lead a dedicated team within MyeloidTx, contributing to both internal research initiatives and vital external collaborations. The successful candidate will leverage their deep expertise in culture of primary hepatocytes and/or iPSC derived hepatocytes/neurons to contribute to optimization of delivery and gene editing efficiency. This is an opportunity for creative, outside-of-the box thinking and rapid learning and growth towards the development of a revolutionary gene editing technology.
Responsibilities:
Qualifications and Education:
Full Time
$182k-236k (estimate)
06/24/2024
08/24/2024
myeloidtx.com
Cambridge, MA
<25